InfoCons Consumer Protection informs you – Darunavir Viatris – Package Leaflet

Before anything else

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

ℹ️ 1. What Darunavir Viatris is and what it is used for

What is Darunavir Viatris ?

Darunavir Viatris contains the active substance darunavir. Darunavir is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. Darunavir works by reducing the amount o f HIV in your body.

This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection.

What it is used for?

Darunavir is used to treat adults and children (3 years of age and above, at least 40 kilograms body weight) who are infected by HIV and

• who have not used antiretroviral medicines before.
• in certain patients who have used antiretroviral medicines before (your doctor will determine this).

Darunavir must be taken in combination with a low dose of cobicistat or ritonavir and other anti -HIV medicines. Your doctor will discuss with you which combination of medicines is best for you.

⚠️ 2. What you need to know before you take Darunavir Viatris

Do not take Darunavir Viatris

• if you are allergic to darunavir or any of the other ingredients of this medicine (listed in section 6) or to cobicistat or ritonavir.
• if you have severe liver problems . Ask your doctor if you are unsure about the severity of your liver disease. Some additional tests might be necessary.

181 Do not combine Darunavir Viatris with any of the following medicines If you are taking any of these, ask your doctor about switching to another medicine.

Medicine Purpose of the medicine Avanafil to treat erectile dysfunction Astemizole or terfenadine to treat allergy symptoms Triazolam and oral (taken by mouth) midazolam to help you sleep and/or relieve anxiety Cisapride to treat some stomach conditions Colchicine (if you have kidney and/or liver problems) to treat gout or familial Mediterranean fever Lurasidone, pimozide, quetiapine or sertindole to treat psychiatric conditions Ergot alkaloids like ergotamine , dihydroergotamine , ergometrine and methylergonovine to treat migraine headaches Amiodarone, bepridil, dronedarone, ivabradine, quinidine, ranolazine to treat certain heart disorders e.g. abnormal heart beat Lovastatin, simvastatin and lomitapide to lower cholesterol levels Rifampicin to treat some infections such as tuberculosis The combination product lopinavir/ritonavir this anti -HIV medicine belongs to the same class as Darunavir Viatris Elbasvir/grazoprevir to treat hepatitis C infection Alfuzosin to treat enlarged prostate Sildenafil to treat high blood pressure in the pulmonary circulation Ticagrelor to help stop the clumping of platelets in the treatment of patients with a history of a heart attack Naloxegol to treat opioid induced constipation Dapoxetine to treat premature ejaculation Domperidone to treat nausea and vomiting Do not combine darunavir with products that contain St John’s wort (Hypericum perforatum) .

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Darunavir Viatris .

Darunavir is not a cure for HIV infection.

People taking darunavir may still develop infections or other illnesses associated with HIV infection.

You must keep in regular contact with your doctor.

People taking darunavir may develop a skin rash. Infrequently a rash may become severe or potentially life -threatening. Please contact your doctor whenever you develop a rash.

In patients taking darunavir and raltegravir (for HIV infection), rashes (generally mild or moderate) may occur more frequently than in patients taking either medicine separately.

Tell your doctor about your situation BEFORE and DURING your treatment Make sure that you check the following points and tell your doctor if any of these apply to you.

• Tell your doctor if you have had problems with your liver before, including hepatitis B or C infection. Your doctor may evaluate how severe your liver disease is before deciding if you can take darunavir.
• Tell your doctor if you have diabetes . Darunavir might increase sugar levels in the blood.
• Tell your doctor immediately if you notice any symptoms of infection (for example enlarged lymph nodes and fever). In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti -HIV treatment is started. It is believed that these symptoms are due to an 182 improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
• In addition to the opportunistic infections, autoimmune disorders (a condition that occurs when the immune system attacks healthy body tissue) may also occur after you start taking medicines for the treatment of your HIV infection. Autoimmune disorders may occur many months after the start of treatment. If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivit y, please inform your doctor immediately to seek necessary treatment.
• Tell your doctor if you have haemophilia . Darunavir might increase the risk of bleeding.
• Tell your doctor if you are allergic to sulphonamides (e.g. used to treat certain infections).
• Tell your doctor if you notice any musculoskeletal problems . Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone). The length of combination antiretroviral therapy, corticosteroid use, alcohol consu mption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease. Signs of osteonecrosis are joint stiffness, aches and pai ns (especially of the hip, knee and shoulder) and difficulty in movement. If you notice any of these symptoms please inform your doctor.

Elderly Darunavir has only been used in limited numbers of patients 65 years or older. If you belong to this age group, please discuss with your doctor if you can use Darunavir Viatris .

Children and adolescents

Darunavir Viatris 800 mg tablets is not for use in children younger than 3 years of age or weighing less than 40 kilograms.

Other medicines and Darunavir Viatris

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines.

There are some medicines that you must not combine with darunavir. These are mentioned above under the heading ‘ Do not combine Darunavir Viatris with any of the following medicines:’ In most cases, darunavir can be combined with anti -HIV medicines belonging to another class [e.g.

NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non -nucleoside reverse transcriptase inhibitors), CCR5 antagonists and FIs (fusion inhibitors)]. Darunavir with cobicistat or ritonavir has not been tested with all PIs (protease inhibitors) and must not be used with other HIV PIs. In some cases dosage of other medicines might need to be changed. Therefore always tell your doctor if you take other ant i-HIV medicines and follow your doctor’s instruction carefully on which medicines can be combined.

The effects of darunavir might be reduced if you take any of the following products. Tell your doctor if you take:

• Phenobarbital, phenytoin (to prevent seizures)
• Dexamethasone (corticosteroid)
• Efavirenz (HIV infection)
• Rifapentine, rifabutin (medicines to treat some infections such as tuberculosis)
• Saquinavir (HIV infection).

The effects of other medicines might be influenced if you take darunavir and your doctor might want to do some additional blood tests . Tell your doctor if you take:

• Amlodipine, diltiazem, disopyramide, carvedilol, felodipine, flecainide, lidocaine, metoprolol, mexiletine, nifedipine, nicardipine , propafenone , timolol, verapamil (for heart disease) as the therapeutic effect or side effects of these medicines may be increased.
• Apixaban, dabigatran etexilate, edoxaban, rivaroxaban, warfarin, clopidogrel (to reduce clotting of the blood) as their therapeutic effect or side effects may be altered.

183 – Oestrogen -based hormonal contraceptives and hormonal replacement therapy. Darunavir might reduce its effectiveness. When used for birth control, alternative methods of non -hormonal contraception are recommended.

• Ethinylestradiol/drospirenone . Darunavir might increase the risk for elevated potassium levels by drospirenone.
• Atorvastatin, pravastatin, rosuvastatin (to lower cholesterol levels). The risk of muscle damage might be increased. Your doctor will evaluate which cholesterol lowering regimen is best for your specific situation.
• Clarithromycin (antibiotic)
• Ciclosporin, everolimus, tacrolimus, sirolimus (for dampening down your immune system) as the therapeutic effect or side effects of these medicines might be increased.
• Corticosteroids including betamethasone, budesonide, fluticasone, mometasone, prednisone, triamcinolone . These medicines are used to treat allergies, asthma, inflammatory bowel diseases, inflammatory conditions of the skin, eyes, joints and muscles and other inflammatory conditions. These medicines are generally taken orally, inhaled, injected or applied to the skin.

If alternatives cannot be used, its use should only take place after medical evaluation and under close monitoring by your doctor for cortic osteroid side effects.

• Buprenorphine/naloxone (medicines to treat opioid dependence)
• Salmeterol (medicine to treat asthma)
• Artemether/lumefantrine (a combination medicine to treat malaria)
• Dasatinib, everolimus, irinotecan, nilotinib, vinblastine, vincristine (to treat cancer)
• Sildenafil, tadalafil, vardenafil (for erectile dysfunction or to treat a heart and lung disorder called pulmonary arterial hypertension)
• Glecaprevir/pibrentasvir (to treat hepatitis C infection)
• Fentanyl, oxycodone, tramadol (to treat pain)
• Fesoterodine, solifenacin (to treat urologic disorders).

Your doctor might want to do some additional tests and t he dosage of other medicines might need to be changed since either their own or darunavir’s therapeutic effect or side effects may be influenced when combined.

Tell your doctor if you take:

• Dabigatran etexilate, edoxaban, warfarin (to reduce clotting of the blood)
• Alfentanil (injectable strong and short -acting painkiller that is used for surgical procedures)
• Digoxin (to treat certain heart disorders)
• Clarithromycin (antibiotic)
• Itraconazole, isavuconazole, fluconazole, posaconazole, clotrimazole (to treat fungal infections). Voriconazole should only be taken after medical evaluation.
• Rifabutin (against bacterial infections)
• Sildenafil, vardenafil, tadalafil (for erectile dysfunction or high blood pressure in the pulmonary circulation)
• Amitriptyline, desipramine, imipramine, nortriptyline, paroxetine, sertraline, trazodone (to treat depression and anxiety)
• Maraviroc (to treat HIV infection)
• Methadone (to treat opiate dependence)
• Carbamazepine, clonazepam (to prevent seizures or to treat certain types of nerve pain)
• Colchicine (to treat gout or familial Mediterranean fever)
• Bosentan (to treat high blood pressure in the pulmonary circulation)
• Buspirone, clorazepate, diazepam, estazolam, flurazepam, midazolam when used as injection, zolpidem (sedative agents)
• Perphenazine, risperidone, thioridazine (to treat psychiatric conditions)
• Metformin (to treat type 2 diabetes).

This is not a complete list of medicines. Tell your healthcare provider about all medicines that you are taking.

Darunavir Viatris with food and drink See section 3 ‘How to take Darunavir Viatris .

Pregnancy and breast -feeding Tell your doctor immediately if you are pregnant or planning to become pregnant. Pregnant women must not take darunavir with ritonavir unless specifically directed by the doctor. Pregnant women should not take darunavir with cobicistat.

Because of the potential for side effects in breast -fed infants, women should not breast -feed if they are receiving Darunavir Viatris .

Breast -feeding is not recommended in women living with HIV because HIV infection can be passed on to the baby in breast milk. If you are breast -feeding, or thinking about breast -feeding, you should discuss it with your doctor as soon as possible.

Driving and using machines

Do not operate machines or drive if you feel dizzy after taking darunavir.

Darunavir Viatris contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium – free’.

💊 3. How to take Darunavir Viatris

Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.

Even if you feel better, do not stop taking darunavir and cobicistat or ritonavir without talking to your doctor.

After therapy has been initiated, the dose or dosage form must not be changed or therapy must not be stopped without instruction of the doctor.

Darunavir Viatris 800 mg tablets are intended for once daily use only.

Dose for adults who have not taken antiretroviral medicines before (your doctor will determine this) The usual dose of darunavir is 800 milligram (2 tablets containing 400 milligram of darunavir or 1 tablet containing 800 milligram of darunavir) once daily.

You must take darunavir every day and always in combination with 150 milligram of cobicistat or 100 milligram of ritonavir and with food. Darunavir cannot work properly without cobicistat or ritonavir and food. You must eat a meal or a snack within 30 minu tes prior to taking your darunavir and cobicistat or ritonavir. The type of food is not important. Even if you feel better, do not stop taking darunavir and cobicistat or ritonavir without talking to your doctor.

Instructions for adults

• Take one 800 milligram tablet at the same time, once a day, every day.
• Take darunavir always together with 150 milligram of cobicistat or 100 milligram of ritonavir.
• Take darunavir with food.
• Swallow the tablet with a drink such as water or milk.
• Take your other HIV medicines used in combination with darunavir and cobicistat or ritonavir as recommended by your doctor.

Dose for adults who have taken antiretroviral medicines before (your doctor will determine this) The dose is either:

• 800 milligram darunavir (2 tablets containing 400 milligram of darunavir or 1 tablet containing 800 milligram of darunavir) together with 150 milligram cobicistat or 100 milligram ritonavir once daily.

OR

• 600 milligram darunavir (2 tablets containing 300 milligram of darunavir or 1 tablet containing 600 milligram of darunavir) together with 100 milligram ritonavir twice daily.

Please discuss with your doctor which dose is right for you.

Dose for children 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kilograms who have not taken antiretroviral medicines before (your child’s doctor will determine this)

• The usual dose of darunavir is 800 milligram (2 tablets containing 400 milligram of darunavir or 1 tablet containing 800 milligram of darunavir) together with 100 milligram ritonavir or 150 milligram of cobicistat once daily.

Dose for children 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kilograms who have taken antiretroviral medicines before (your child’s doctor will determine this) The dose is either:

• 800 milligram darunavir (2 tablets containing 400 milligram of darunavir or 1 tablet containing 800 milligram of darunavir) together with 100 milligram ritonavir or 150 milligram of cobicistat once daily.

OR

• 600 milligram darunavir (2 tablets containing 300 milligram of darunavir or 1 tablet containing 600 milligram of darunavir) together with 100 milligram ritonavir twice daily.

Please discuss with your doctor which dose is right for you.

Instructions for children 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kilograms

• Take 800 milligram darunavir (2 tablets containing 400 milligram of Darunavir Viatris or 1 tablet containing 800 milligram of Darunavir Viatris ) at the same time, once a day, every day.
• Take darunavir always together with 100 milligram of ritonavir or 150 milligram of cobicistat.
• Take darunavir with food.
• Swallow the tablets with a drink such as water or milk.
• Take your other HIV medicines used in combination with darunavir and ritonavir or cobicistat as recommended by your doctor.

If you take more Darunavir Viatris than you should

Contact your doctor, pharmacist or nurse immediately.

If you forget to take Darunavir Viatris

If you notice within 12 hours , you must take the tablets immediately. Always take with cobicistat or ritonavir and food. If you notice after 12 hours , then skip the intake and take the next doses as usual.

Do not take a double dose to make up for a forgotten dose.

If you vomit after taking Darunavir Viatris and cobicistat or ritonavir If you vomit within 4 hours of taking the medicine, another dose of Darunavir Viatris and cobicistat or ritonavir should be taken with food as soon as possible. If you vomit more than 4 hours after taking the medicine, then you do not need to take another dose of Darunavir Viatris and cobicistat or ritonavir until the next regularly scheduled time.

Contact your doctor if you are uncertain about what to do if you miss a dose or vomit.

Do not stop taking Darunavir Viatris without talking to your doctor first Anti-HIV medicines may make you feel better. Even when you feel better, do not stop taking Darunavir Viatris . Talk to your doctor first.

186 If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

❗ 4. Possible side effects

During HIV therapy there may be an increase in weight and in levels of blood lipids and glucose. This is partly linked to restored health and life style, and in the case of blood lipids sometimes to the HIV medicines themselves. Your doctor will test for t hese changes.

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor if you develop any of the following side effects Liver problems that may occasionally be severe have been reported. Your doctor should do blood tests before you start darunavir. If you have chronic hepatitis B or C infection, your doctor should check your blood tests more often because you have an increa sed chance of developing liver problems. Talk to your doctor about the signs and symptoms of liver problems. These may include yellowing of your skin or whites of your eyes, dark (tea coloured) urine, pale coloured stools (bowel movements), nausea, vomitin g, loss of appetite, or pain, aching, or pain and discomfort on your right side below your ribs.

Skin rash (more often when used in combination with raltegravir), itching. The rash is usually mild to moderate. A skin rash might also be a symptom of a rare severe situation. It is therefore important to talk to your doctor if you develop a rash. Your do ctor will advise you how to deal with your symptoms or whether darunavir must be stopped.

Other severe side effects were diabetes (common), and inflammation of the pancreas (uncommon).

Very common side effects (may affect more than 1 in 10 people)

• diarrhoea.

Common side effects (may affect up to 1 in 10 people)

• vomiting, nausea, abdominal pain or distension, dyspepsia, flatulence
• headache , tiredness, dizziness, drowsiness, numbness, tingling or pain in hands or feet, loss of strength, difficulty falling asleep.

Uncommon side effects (may affect up to 1 in 100 people)

• chest pain, changes in electrocardiogram, rapid heart beating
• decreased or abnormal skin sensitivity, pins and needles, attention disturbance, loss of memory, problems with your balance
• difficulty breathing, cough, nosebleed, throat irritation
• inflammation of the stomach or mouth, heartburn, retching, dry mouth, discomfort of the abdomen, constipation, belching
• kidney failure, kidney stones, difficult discharge of urine, frequent or excessive passage of urine, sometimes at night
• urticaria, severe swelling of the skin and other tissues (most often the lips or the eyes), eczema, excessive sweating, night sweats, hair loss, acne, scaly skin, colouration of nails
• muscle pain, muscle cramps or weakness, pain in extremity, osteoporosis
• slowing down of the thyroid gland function. This can be seen in a blood test.
• high blood pressure, flushing
• red or dry eyes
• fever, swelling of lower limbs due to fluids, malaise, irritability, pain
• symptoms of infection, herpes simplex
• erectile dysfunction, enlargement of breasts
• sleeping problems, sleepiness, depression, anxiety, abnormal dreams, decrease in sexual drive

Rare side effects (may affect up to 1 in 1,000 people)

• a reaction called DRESS [severe rash, which may be accompanied by fever, fatigue, swelling of the face or lymph glands, increase of eosinophils (type of white blood cells), effects on liver, kidney or lung] 187 – heart attack, slow heart beating, palpitations
• visual disturbance
• chills, feeling abnormal
• a feeling of confusion or disorientation, altered mood, restlessness
• fainting, epileptic fits, changes or loss of taste
• mouth sores, vomiting blood, inflammation of the lips, dry lips, coated tongue
• running nose
• skin lesions, dry skin
• stiffness of muscles or joints, joint pain with or without inflammation
• changes in some values of your blood cells or chemistry. These can be seen in the results of blood and/or urine tests. Your doctor will explain these to you. Examples are: increase in some white blood cells
• darunavir crystals in the kidney causing kidney disease .

Some side effects are typical for anti -HIV medicines in the same family as darunavir. These are:

• muscle pain, tenderness or weakness. On rare occasions, these muscle disorders have been serious.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V . By reporting side effects you can help provide more information on the safety of this medicine.

🌡️ 5. How to store Darunavir Viatris

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton, blister and on the bottle after EXP. The expiry date refers to the last day of that month.

For blisters with plastic on one side and aluminium on the other: Do not store above 25°C.

For blisters with aluminium on both sides: This medicine does not require any special storage conditions.

For bottles: Once opened, use within 90 days. This medicine does not require any special storage conditons.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away any medicines you no longer use. These measures will help protect the environment.

📦 6. Contents of the pack and other information

What Darunavir Viatris contains

• The active substance is darunavir. Each tablet contains 800 milligram of darunavir.
• The other ingredients are colloidal anhydrous silica, cellulose microcrystalline, crospovidone, sodium starch glycolate, hypromellose, magnesium stearate. The film -coating contains polyvinyl alcohol partially hydrolysed, titanium dioxide (E171), macrogol a nd talc.

What Darunavir Viatris looks like and contents of the pack

Darunavir Viatris 800 mg film -coated tablets are white to off -white, oval shaped, with two curved sides, marked with M on one side and DV8 on the other side.

188 Darunavir Viatris 800 mg film -coated tablets are available in blister packs containing 30 tablets and in plastic bottles containing 30, 60 and 90 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Viatris Limited Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

Manufacturers

Mylan Hungary Kft H-2900 Komárom, Mylan utca 1 Hungary McDermott Laboratories Limited trading as Gerard Laboratories 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13 Ireland Mylan Germany GmbH Zweigniederlassung Bad Homburg v. d. Hoehe, Benzstrasse 1 Bad Homburg v. d. Hoehe Hessen, 61352 Germany For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

België/Belgique/Belgien Viatris Tél/Tel: + 32 (0)2 658 61 00 Lietuva Viatris UAB Tel: +370 5 205 1288 България Майлан ЕООД Тел: +359 2 44 55 400 Luxembourg/Luxemburg Viatris Tél/Tel: + 32 (0)2 658 61 00 (Belgique/Belgien) Česká republika Viatris CZ s.r.o.

Tel: + 420 222 004 400 Magyarország Viatris Healthcare Kft.

Tel.: + 36 1 465 2100 Danmark Viatris ApS Tlf: +45 28 11 69 32 Malta V.J. Salomone Pharma Ltd Tel: + 356 21 22 01 74 Deutschland Viatris Healthcare GmbH Tel: +49 800 0700 800 Nederland Mylan BV Tel: +31 (0)20 426 3300 Eesti Viatris OÜ Tel: + 372 6363 052 Norge Viatris AS Tlf: + 47 66 75 33 00 189 Ελλάδα Viatris Hellas Ltd Τηλ: +30 210 0 100 002 Österreich Viatris Au stria GmbH Tel: +43 1 86390 España Viatris Pharmaceuticals, S.L. .

Tel: + 34 900 102 712 Polska Viatris Healthcare Sp. z o.o.

Tel.: + 48 22 546 64 00 France Viatris Santé Tél: +33 4 37 25 75 00 Portugal Mylan, Lda.

Tel: + 351 214 127 200 Hrvatska Viatris Hrvatska d.o.o.

Tel: +385 1 23 50 599 România BGP Products SRL Tel: +40 372 579 000 Ireland Viatris Limited Tel: +353 1 8711600 Slovenija Viatris d.o.o.

Tel: + 386 1 23 63 180 Ísland Icepharma hf .

Sími : +354 540 8000 Slovenská republika Viatris Slovakia s.r.o.

Tel: +421 2 32 199 100 Italia Viatris Italia S.r.l Tel: + 39 (0) 2 612 46921 Suomi/Finland Viatris O y Puh/Tel: +358 20 720 9555 Κύπρος GPA Pharmaceuticals Ltd Τηλ: + 357 22863100 Sverige Viatris AB Tel: +46 (0)8 630 19 00 Latvija Viatris SIA Tel: +371 676 055 80 United Kingdom (Northern Ireland) Mylan IRE Healthcare Limited Tel: +353 18711600 This leaflet was last revised in {MM/YYYY}.

Other sources of information Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.

📄 Package Leaflet – official source

This article reproduces the information in the official package leaflet, as authorised in the European Union. You can consult the original document here: Product information Darunavir Viatris (PDF, ec.europa.eu).

You can check this medicine at any time in the Union Register of medicinal products (EU number EU/1/16/1140).

⚠️ Important: This article is for information purposes only and does not replace medical advice or the package leaflet inside the medicine box. Read the leaflet carefully before use. For any questions about your treatment, talk to your doctor or pharmacist. If you experience side effects, tell your doctor or pharmacist and report them through your national reporting system.